Clazakizumab in Chronic Active Antibody-Mediated Kidney Transplant Rejection: Results of the IMAGINE Phase 3 Study

被引：0
|
作者：
Djamali, Arjang [1 ]
Bohmig, Georg [4 ]
Chadban, Steven J. [5 ]
Kumar, Deepali [6 ]
Mannon, Roslyn B. [7 ]
van Gelder, Teun [8 ]
Schultz-Hauser, Gabriele [9 ]
Alperovich Lehrer, Gabriela [10 ]
Preiss, Ralph [11 ]
Raychaudhuri, Aparna [2 ]
Lee, Laurie [2 ]
Nickerson, Peter W. [3 ]
机构：
[1] Maine Med Ctr, Portland, ME USA
[2] CSL Behring LLC, King Of Prussia, PA USA
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Med Univ Vienna, Vienna, Austria
[5] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[6] Univ Toronto, Toronto, ON, Canada
[7] Univ Nebraska Med Ctr, Omaha, NE USA
[8] Leiden Univ Med Ctr, Leiden, Netherlands
[9] CSL Behring, Marburg, Germany
[10] CSL Vifor, Madrid, Spain
[11] CSL Behring, Bern, Switzerland
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024ktr5vxvn
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-OR84
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
    Hsien-Fu Chiu
    Mei-Chin Wen
    Ming-Ju Wu
    Cheng-Hsu Chen
    Tung-Min Yu
    Ya-Wen Chuang
    Shih-Ting Huang
    Shang-Feng Tsai
    Ying-Chih Lo
    Hao-Chung Ho
    Kuo-Hsiung Shu
    BMC Nephrology, 21
  • [42] Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
    Farsad Eskandary
    Michael Dürr
    Klemens Budde
    Konstantin Doberer
    Roman Reindl-Schwaighofer
    Johannes Waiser
    Markus Wahrmann
    Heinz Regele
    Andreas Spittler
    Nils Lachmann
    Christa Firbas
    Jakob Mühlbacher
    Gregor Bond
    Philipp F. Halloran
    Edward Chong
    Bernd Jilma
    Georg A. Böhmig
    Trials, 20
  • [43] Treatment of chronic active antibody-mediated rejection in renal transplant recipients - a single center retrospective study
    Chiu, Hsien-Fu
    Wen, Mei-Chin
    Wu, Ming-Ju
    Chen, Cheng-Hsu
    Yu, Tung-Min
    Chuang, Ya-Wen
    Huang, Shih-Ting
    Tsai, Shang-Feng
    Lo, Ying-Chih
    Ho, Hao-Chung
    Shu, Kuo-Hsiung
    BMC NEPHROLOGY, 2020, 21 (01)
  • [44] Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study
    Kanzelmeyer, Nele Kirsten
    Zuerbig, Petra
    Mischak, Harald
    Metzger, Jochen
    Fichtner, Alexander
    Ruszai, Kristzina Heindl
    Seemann, Tomas
    Hansen, Matthias
    Wygoda, Simone
    Krupka, Kai
    Toenshoff, Burkhard
    Melk, Anette
    Pape, Lars
    TRANSPLANT INTERNATIONAL, 2019, 32 (01) : 28 - 37
  • [45] Not all transplant glomerulopathy related to chronic antibody-mediated rejection
    Akalin, Enver
    Silva, Mariel Barbachan e
    Mustofa, Sadia
    Bao, Yi
    Broin, Pilib o
    TRANSPLANTATION, 2024, 108 (9S)
  • [46] Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation
    Muller, Yannick D.
    Ghaleb, Nseir
    Rotman, Samuel
    Vionnet, Julien
    Halfon, Matthieu
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    TRANSPLANT INTERNATIONAL, 2018, 31 (04) : 451 - 455
  • [47] RITUXIMAB AS MONOTHERAPY FOR THE TREATMENT OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Muller, Yannick
    Ghaleb, Nseir
    Rotman, Samuel
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    TRANSPLANT INTERNATIONAL, 2017, 30 : 553 - 554
  • [48] Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies
    Aziz, Fahad
    Parajuli, Sandesh
    Jorgenson, Margaret
    Garg, Neetika
    Manchala, Venkata
    Yousif, Elsadiq
    Mandelbrot, Didier
    Hidalgo, Luis
    Mohamed, Maha
    Zhong, Weixiong
    Djamali, Arjang
    TRANSPLANTATION DIRECT, 2022, 8 (09): : E1360
  • [49] Chronic Active Antibody-Mediated Rejection Following COVID-19 Infection in a Kidney Transplant Recipient: A Case Report
    Abuzeineh, Mohammad
    Tariq, Anam
    Rosenberg, Avi
    Brennan, Daniel C.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (04) : 1202 - 1206
  • [50] Clinical Outcome of Rituximab and Intravenous Immunoglobulin Combination Therapy in Kidney Transplant Recipients with Chronic Active Antibody-Mediated Rejection
    Ban, Tae Hyun
    Yu, Ji Hyun
    Chung, Byung Ha
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    ANNALS OF TRANSPLANTATION, 2017, 22 : 468 - 474
12345